ABAT and epilepsy: The effects of VPA associated with its prescription for the treatment of seizure disorders, including epilepsy, are primarily mediated by its activities as an inhibitor of GABA transaminase and blocker of voltage-gated sodium channels and T-type calcium channels (Chateauvieux et al., 2010).